RAHBAR
RAHBAR MBBSYear 03 • Research & Evidence-Based Medicine
← Year 03 Subjects
YEAR 03 • CLINICAL TRANSITION

Research & Evidence-Based Medicine

20 learning units • 100 chapter sections • 200 explained questions. Build a question, judge the evidence and connect the answer with the person receiving care.

Original RAHBAR study material for the Year 3 learning pathway. Educational examples support supervised learning; institutional research and clinical requirements still apply. References & further reading ↓
MODULE 13 / 20

Diagnostic Accuracy & Test Interpretation

Use a two-by-two table to distinguish test characteristics from the probability a patient has disease.

Quick revision ↓   Medical Dictionary

01Start with the table

Compare the index test with an appropriate reference standard in a clinically relevant sample. Classify results as true positive, false positive, false negative and true negative. Sensitivity is the proportion of people with disease testing positive; specificity is the proportion without disease testing negative. State which threshold defines positivity. A reference standard can itself be imperfect, so agreement is not automatically equivalent to truth.

02Predictive values and prevalence

Positive predictive value is the proportion of positive results that truly have disease; negative predictive value is the proportion of negative results without disease. These depend strongly on disease frequency in the tested population. Even a reasonably accurate test can produce many false positives when disease is uncommon. Use the patient's pretest context rather than importing a predictive value from a very different population.

03Likelihood ratios and updating

The positive likelihood ratio is sensitivity divided by one minus specificity; the negative likelihood ratio is one minus sensitivity divided by specificity. Convert pretest probability to odds, multiply by the relevant likelihood ratio, then convert odds back to probability. A likelihood ratio of one leaves odds unchanged. Test characteristics may vary across settings and disease spectra, so transportability should still be assessed.

04Worked two-by-two example

Among 100 people, 20 have disease. A test detects 16 of those 20 and is negative in 72 of the 80 without disease. Thus TP=16, FN=4, TN=72 and FP=8. Sensitivity is 80%, specificity 90%, PPV 16/24 or 66.7%, and NPV 72/76 or 94.7%. LR+ is 8 and LR− about 0.22. Keep each denominator visible when interpreting these different questions.

05Appraise the accuracy study

Look for a representative clinical spectrum, prespecified thresholds, independent interpretation and appropriate reference testing regardless of index result. Verifying only positive tests can bias estimates. Avoid an artificial comparison of obvious severe cases against exceptionally healthy controls when clinical use involves uncertain presentations. A ROC curve shows threshold trade-offs; a good area under that curve does not establish improved patient outcomes from using the test.

Diagnostic two-by-two table

Illustrative sample: 100 people, 20 with disease
Index testDisease presentDisease absent
PositiveTP = 16FP = 8
NegativeFN = 4TN = 72

Sensitivity = 16/20 • Specificity = 72/80 • PPV = 16/24 • NPV = 72/76.

High-Yield Revision

  • Sensitivity and specificity condition on disease status.
  • Predictive values condition on the test result.
  • Post-test odds = pretest odds × likelihood ratio.

Common Pitfalls

  • Do not confuse high sensitivity with a high positive predictive value.
  • A test with good accuracy may still lack evidence of clinical benefit.

References & Further Reading

Use the full methods and relevant chapters when appraising a paper. These sources support further study; the examples and questions above are original teaching exercises.

Reference review: 25 September 2026. Consult current institutional guidance for project approval and clinical decisions.